Key result
Chemotherapy alone or with surgery resulted in survival in all 5 patients who completed treatment, whereas the 2 patients who did not complete chemotherapy died.
Why the study?
Does chemotherapy improve survival in patients with malignant fibrous histiocytoma of bone?
Case Report (n=7)
Does chemotherapy improve survival in patients with malignant fibrous histiocytoma of bone?
Chemotherapy, either alone or with surgery, appears to improve survival and prevent recurrence in patients with malignant fibrous histiocytoma of bone.
Answers are grounded in this paper and cite their sources.
May support chemotherapy completion in MFH of bone; leaves open confirmation in prospective trials.
Seven patients have been treated for malignant fibrous histiocytoma (MFH) of bone since the end of 1977. One patient received no chemotherapy, and one did not complete attempted chemotherapy. Both died, 7 and 51 months after diagnosis, respectively. The remaining five patients completed chemotherapy. Two first underwent a primary amputation, whereas the other three received primary chemotherapy with histologic evaluation of the effect. These patients showed a complete remission. The five patients who completed chemotherapy are all still alive, without indications of metastases or local recurrence. Although the number of cases is small, a 25- to 58-months (mean, 45) survival, in five patients treated either with chemotherapy alone or chemotherapy and surgery, is surprisingly good in view of previous experience with this tumor. In some of these patients, the authors were able to document an absence of any viable tumor following chemotherapy.
No takes yet. Share an insight, caveat, or question.
Heeten et al. (1985) conducted a case report in Malignant fibrous histiocytoma (MFH) of bone (n=7). Chemotherapy vs. No chemotherapy or incomplete chemotherapy was evaluated on Survival. Chemotherapy alone or with surgery resulted in survival in all 5 patients who completed treatment, whereas the 2 patients who did not complete chemotherapy died.
Synapse has enriched 10 related papers. Consider them for comparative context: